SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Under the Securities Exchange Act of 1934
SCHEDULE 13G/A
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Horizon Pharmacies, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
439902107
(CUSIP Number)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|X| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
Page 1 of 6 Pages
<PAGE>
SCHEDULE 13G/A
CUSIP No. 439902107 Page 2 of 6 Pages
- ------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
GINTEL ASSET MANAGEMENT, INC.
IRS #06-0871969
- ------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
GINTEL ASSET MANAGEMENT, INC. 365,000
- ------------------------------------------------------------------------------
3) SEC USE ONLY
- ------------------------------------------------------------------------------
4) CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
- ------------------------------------------------------------------------------
5) SOLE VOTING POWER
365,000
NUMBER -------------------------------------------------
OF 6) SHARED VOTING POWER
SHARES
BENEFICIALLY -------------------------------------------------
OWNED BY 7) SOLE DISPOSITIVE POWER
EACH 365,000
REPORTING -------------------------------------------------
PERSON 8) SHARED DISPOSITIVE POWER
WITH
- ------------------------------------------------------------------------------
9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
365,000
- ------------------------------------------------------------------------------
10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES [ ]
- ------------------------------------------------------------------------------
11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.19%
- ------------------------------------------------------------------------------
12) TYPE OF REPORTING PERSON
IA
- ------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13G/A
Item 1(a). Name of Issuer:
Horizon Pharmacies, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
501 West Main
Denison, TX 75020
Item 2(a). Name of Person Filing:
GINTEL ASSET MANAGEMENT, INC.
Item 2(b). Address of Principal Business Office or, if None, Residence:
6 Greenwich Office Park
Greenwich, CT 06831
Item 2(c). Citizenship:
CONNECTICUT CORPORATION
Item 2(d). Title of Class of Securities:
Common Stock $.01 par value
Item 2(e). CUSIP Number:
439902107
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b), or
240.13d-2(b) or (c), check whether the person filing is a:
(a)|_| Broker or Dealer Registered Under Section 15 of the Act (15
U.S.C. 78o)
(b)|_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c)
(c)|_| Insurance Company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c)
(d)|_| Investment Company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8)
(e)|X| Investment Adviser in accordance with
ss.240.13d-1(b)(1)(ii)(E)
Page 3 of 5 Pages
<PAGE>
(f)|_| Employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F)
(g)|_| Parent Holding Company or control person in accordance with
ss.240.13d-1(b)(ii)(G)
(h)|_| Savings Association as defined in ss.3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813)
(i)|_| Church plan that is excluded from the definition of an
investment company under ss.3(c)(15) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3)
(j)|_| Group, in accordance with ss.240.13d-1(b)(ii)(J)
Item 4. Ownership.
Mr. Robert M. Gintel, Chief Executive Officer and 100% shareholder of Gintel
Asset Managment, Inc., is also controlling partner of Gintel & Co. Limited
Partnership and, Owner of TransAqua L.L.C., and senior member of Gintel Equity
Managment, L.L.C., which acts as investment advisor to Gintel Partners Fund.
(a) Amount beneficially owned: 365,000
(b) Percent of class: 6.19%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 365,000
(ii) Shared power to vote or to direct the vote: -0-
(iii) Sole power to dispose or to direct the disposition
of: 365,000
(iv) Shared power to dispose or to direct the
disposition of: -0-
Page 4 of 5 Pages
<PAGE>
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Page 5 of 6 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
Statement is true, complete and correct.
GINTEL ASSET MANAGEMENT, INC.
/s/ Stephen G. Stavrides
----------------------------
BY: Stephen G. Stavrides
President
DATE: June 5, 2000
Page 6 of 6 Pages
